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Abstract

Regional alterations in kinetics of catecholamine uptake are due in part to variations in clearance
mechanisms. The rate of clearance is a critical determinant of the strength of catecholamine signaling.
Catecholamine transmission in the nucleus accumbens core (NAcc) and basolateral amygdala (BLA) is
of particular interest due to involvement of these regions in cognition and motivation. Previous work
has shown that catecholamine clearance in the NAcc is largely mediated by the dopamine transporter
(DAT), but clearance in the BLA is less DAT‐dependent. A growing body of literature suggests that
organic cation transporter 3 (OCT3) also contributes to catecholamine clearance in both regions.
Consistent with different clearance mechanisms between regions, catecholamine clearance is more
rapid in the NAcc than in the BLA, though mechanisms underlying this have not been resolved. We
compared the expression of DAT and OCT3 and their contributions to catecholamine clearance in the
NAcc and BLA. We found DAT protein levels were ~ 4‐fold higher in the NAcc than in the BLA, while
OCT3 protein expression was similar between the two regions. Immunofluorescent labeling of the two
transporters in brain sections confirmed these findings. Ex vivo voltammetry demonstrated that the
magnitude of catecholamine release was greater, and the clearance rate was faster in the NAcc than in
the BLA. Additionally, catecholamine clearance in the BLA was more sensitive to the OCT3 inhibitor
corticosterone, while clearance in the NAcc was more cocaine sensitive. These distinctions in
catecholamine clearance may underlie differential effects of catecholamines on behavioral outputs
mediated by these regions.
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OCT3 has a greater role in catecholamine uptake in the BLA than in the NAcc. The DAT is more highly
expressed in the NAcc than the BLA, whereas OCT3 is expressed similarly between the regions. In the
BLA, uptake is far more inhibited by corticosterone (an OCT3 blocker) than it is within the NAcc.Abs.
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ACSF artificial cerebrospinal fluid
BLA basolateral amygdala
CA catecholamine
CORT corticosterone
DAT KO dopamine transporter knockout mice
DAT dopamine transporter
NAcc nucleus accumbens core
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•

NET norepinephrine transporter
OCT3 organic cation transporter 3
PB phosphate buffer
PBS phosphate‐buffered saline
PMAT plasma membrane monoamine transporter

INTRODUCTION

The nucleus accumbens core (NAcc) and basolateral amygdala (BLA) receive dopaminergic projections
from the ventral tegmental area (VTA) that have been implicated in regulating aspects of cognition
(Churchwell, Morris, Heurtelou, & Kesner, 2009; Fuxe, Borroto‐Escuela, Romero‐Fernandez, Zhang, &
Agnati, 2013; Li, Zuo, Yu, Ping, & Cui, 2015; Touzani, Bodnar, & Sclafani, 2008; Perez de la Mora,
Jacobsen, Crespo‐Ramirez, Flores‐Gracia, Fuxe, 2008), fear (Klumpers, Morgan, Terburg, Stein, & van
Honk, 2015; Li & McNally, 2015; Stevenson & Gratton, 2004), and motivated behaviors (Ballester
Gonzalez, Dvorkin‐Gheva, Silva, Foster, & Szechtman, 2015; Shiflett & Balleine, 2010; Simmons &
Neill, 2009). Though both NAcc and BLA are implicated in these behaviors, dopamine signaling seems
to have opposite effects in the two areas. Dopamine neurotransmission in the NAcc has been
historically linked to the psychomotor stimulating and rewarding effects of drugs of abuse (Baik, 2013;
Fish, DiBerto, Krouse, Robinson, & Malanga, 2014; Nakamura et al., 2014), and functional reduction of
dopamine transmission in this region has been observed following chronic drug exposure and
withdrawal (Markou & Koob, 1992; Rose et al., 2016; Schulteis, Markou, Cole, & Koob, 1995; Siciliano,
Calipari, Ferris, & Jones, 2015; Siciliano et al., 2016). The behavioral effects of dopamine in the BLA are
often the opposite. For example, augmented dopamine in the NAcc is linked to positive‐affective states
(Baik, 2013; Fish et al., 2014; Nakamura et al., 2014), while increased dopamine in the BLA is associated
with negative affect or anxiogenic states (Bananej, Karimi‐Sori, Zarrindast, & Ahmadi, 2012; Diaz,
Chappell, Christian, Anderson, & McCool, 2011; Karkhanis, Rose, Huggins, Konstantopoulos, &
Jones, 2015). Further, dopamine is decreased in the NAcc following chronic adolescent social isolation
in rats, a model of early life stress, whereas dopamine release is increased in the BLA using the same
paradigm (Karkhanis et al., 2015).
Catecholamine neurotransmission can be influenced by both release and clearance mechanisms, which
can differ widely between brain regions. Multiple mechanisms of dopamine clearance have been
delineated, including uptake by both high‐affinity (Budygin, John, Mateo, & Jones, 2002; Gainetdinov,
Jones, & Caron, 1999; Gainetdinov, Jones, Fumagalli, Wightman, & Caron, 1998) and low‐affinity
transporters (Baganz, Horton, Martin, Holmes, & Daws, 2010; Duan & Wang, 2010; Gasser, Lowry, &
Orchinik, 2006; Hill & Gasser, 2013; Lips et al., 2005), in addition to enzymatic degradation (Akil
et al., 2003; Napolitano, Bellini, Borroni, Zurcher, & Bonuccelli, 2003) and diffusion (Kehr, Hoistad, &
Fuxe, 2000; Trouillon, Lin, Mellander, Keighron, & Ewing, 2013). Dopamine clearance is regulated by
distinct mechanisms in the NAcc and BLA. Dopamine transporters (DAT), are high‐affinity, low‐capacity
transport proteins abundantly expressed in the NAcc (Karkhanis et al., (2015); Gainetdinov et al., 1998;
Gainetdinov et al., 1999; Budygin et al., 2002), but are less abundant in the BLA. A growing body of
literature suggests that the organic cation transporter 3 (OCT3) (Baganz et al., 2010; Duan &
Wang, 2010; Gasser, 2018; Gasser, Hurley, Chan, & Pickel, 2017; Gasser et al., 2006; Graf et al., 2013;
Hill & Gasser, 2013; Iversen & Salt, 1970; Lightman & Iversen, 1969; Wieland, Hayer‐Zillgen, Bonisch, &

Bruss, 2000), which is expressed in both the NAcc (Graf et al., 2013) and BLA (Hill & Gasser, 2013), can
mediate uptake of a variety of monoamine species including serotonin (Baganz et al., 2010; Schmitt
et al., 2003), norepinephrine (Duan & Wang, 2010), and dopamine (Gasser et al., 2006; Hill &
Gasser, 2013). Compared to the DAT, OCT3 has a lower affinity for dopamine (Duan & Wang, 2010),
but a higher capacity for dopamine transport (Zhu, Appel, Grundemann, & Markowitz, 2010). The
relative contributions of OCT3 and the DAT to dopamine clearance in the NAcc and BLA have not been
directly investigated. Elucidating this relationship could provide unique pharmacological treatment
strategies for ameliorating substance use disorders and anxiety‐related disorders by regulating distinct
dopamine transmission in the NAcc and BLA.
Exposure to stressors engages the hypothalamic–pituitary–adrenal (HPA) axis (Franco et al., 2016; Hek
et al., 2013) to increase synthesis and release of corticosteroid hormones (predominantly cortisol in
humans, and corticosterone (CORT) in rodents) (Jones, Gupton, & Curtis, 2016; Jung et al., 2014;
Ottenweller, Natelson, Pitman, & Drastal, 1989; Smyth et al., 2015). In the NAcc, CORT decreases the
rate of dopamine clearance (Graf et al., 2013) and thereby increases the duration of neurotransmitter
action in this region. CORT and other corticosteroids acutely and directly inhibit OCT3‐mediated
transport (Baganz et al., 2010; Wieland et al., 2000); in fact, recent work has demonstrated that the
pharmacological interaction between CORT and OCT3 (Graf et al., 2013) is functionally analogous to
uptake inhibition by cocaine of the DAT (Grundemann, Schechinger, Rappold, & Schomig, 1998). CORT
treatment, likely by inhibiting OCT3‐mediated clearance, has been shown to augment extracellular
concentrations of serotonin (Baganz et al., 2010), norepinephrine (Ayala‐Lopez et al., 2015) and
dopamine (Graf et al., 2013). Taken together, this suggests that OCT3 blockade may augment
extracellular catecholamine levels (Baganz et al., 2010; Duan & Wang, 2010; Gasser et al., 2006; Hill &
Gasser, 2013; Schmitt et al., 2003). Notably, OCT3 is densely expressed in the BLA (Hill & Gasser, 2013)
where CORT may exert similar inhibitory effects upon OCT3 to decrease catecholamine clearance. By
regulating the duration of released catecholamines, clearance mechanisms contribute greatly to the
extent to which receptors are activated on target cells and thus can have powerful effects on behavior
modulated by catecholamines.
Previous work has shown that the catecholamine clearance rate in the NAcc is significantly faster than
clearance rates in the BLA (Jones, Garris, Kilts, & Wightman, 1995). It is plausible that this distinction is
due to differences in both the specific transporters expressed, and the density of transporter
expression in the two areas. Our laboratory has previously shown that DAT protein expression is lower
in the BLA than in the NAcc (Karkhanis et al., 2015) and that the apparent affinity of transporters for
catecholamines is lower in the BLA compared to the NAcc (Jones et al., 1995). Together, these factors
likely contribute to regional differences in clearance rates. In consideration of these data, we examined
the localization and expression levels of DAT and OCT3 in the NAcc and BLA using immunofluorescence
and Western blot and assessed the functional contributions of DAT and OCT3 to catecholamine
clearance in the two regions of drug‐naïve rats using ex vivo fast‐scan cyclic voltammetry.

METHODS
Experimental animals

Male Sprague‐Dawley rats (n = 6–10 per group, 9–10 months old, Harlan Laboratories, Indianapolis, IN)
and homozygote DAT knockout (DAT KO) mice were used for experiments. DAT KO mice were bred in‐
house via crossing heterozygous DAT+/− 129SvJ and C57BL/6 mice (Lack, Jones, & Roberts, 2008), and
then breeding resultant DAT+/− mice. Tissue samples were obtained from DAT+/− × DAT+/− breeding pair
litters and digested prior to phenol:chloroform DNA extraction. Polymerase chain reaction was run
with forward and reverse oligonucleotide primers for DAT to verify animals with full DAT KO. All
animals were maintained on a 12:12 light cycle and given standard rodent chow and water ad libitum,
and all experiments were performed in the dark phase of the animals' light cycle. Animal care and
handling, as well as experimental protocols, were approved by the Wake Forest School of Medicine
Institutional Animal Care and Use Committee and adhered to all National Institutes of Health Animal
Care Guidelines.

Brain slice preparation for fast‐scan cyclic voltammetry

Animals were deeply anesthetized with isoflurane gas in an induction chamber and then rapidly
decapitated. Brains were removed and placed into ice‐cold, pre‐oxygenated (95% O2/5% CO2) artificial
cerebrospinal fluid (ACSF; in mM: 126 NaCl, 2.5 KCl, 1.2 NaH2PO4, 1.4 CaCl2, 2.4 MgCl2, 25 NaHCO3, 11.0
glucose, 0.4 l‐ascorbic acid; pH adjusted to 7.4). A vibrating tissue slicer (Leica Biosystems, Buffalo
Grove, IL, USA) was used to prepare coronal brain slices (400µm thick from rats, 300 µm thick from
mice) containing the NAcc (both rats and mice) and BLA (rats only). NAcc and BLA tissue for protein
analysis was excised from slices by hand.

Western blot hybridization

DAT and OCT3 protein levels were quantified using Western blot hybridization following methods
described previously (Giros, Jaber, Jones, Wightman, & Caron, 1996), with slight alterations for OCT3
blots described below. Tissue samples from rats were homogenized in radioimmunoprecipitation assay
(RIPA) buffer (150 mM NaCl, 1.0% Triton X‐100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl
sulfate (SDS), 50 mM Trizma Base, pH 8.0) and centrifuged at 12,000 g for 30 min. Protein
concentrations were determined using a BCA protein assay kit (Thermo Scientific, Rockford, IL) and
Molecular Devices Spectra Max 384 Plus spectrophotometer (Sunnyvale, CA) running SoftMax Pro
software. A MagicMark™ XP molecular weight ladder (LC5602; Thermo Fisher Scientific, Grand Island,
NY) and 30μg of protein were loaded into 4%–12% NuPAGE Bis‐Tris gels (NP0321BOX; Thermo Fisher
Scientific). Proteins from the gel were transferred onto a polyvinylidene difluoride membrane and
probed using the following primary antibody dilutions: DAT (1:4,000; 2,231, EMD Millipore, Billerica,
MA), OCT3 (1:1,000; (OCT31‐A, Alpha Diagnostic Int., San Antonio, TX), and β‐actin (1:4,000; ab8229,
Abcam, Cambridge, MA). A horseradish peroxidase (HRP)‐conjugated secondary antibody was used
(1:5,000 for DAT and β‐actin, 1:4,000 for OCT3) (65‐6120, Thermo Fisher Scientific, Grand Island, NY), in
combination with Pierce ECL chemiluminescence (32,106, Thermo Fisher Scientific, Grand Island, NY).
Blots were exposed using a Bio‐Rad ChemiDoc imaging system, and the band signal intensity was
assessed using QuantityOne software (Bio‐Rad, Hercules, CA).

Perfusion and histology

Rats were deeply anesthetized by intraperitoneal injection of sodium pentobarbital (100 mg/kg) and
were transcardially perfused with ice‐cold 0.05 M phosphate‐buffered saline followed by 4%
paraformaldehyde in 0.1 M sodium phosphate buffer (PB, pH 7.4). Following perfusion, brains were
removed and post‐fixed in the 4% paraformaldehyde solution for 12 hr at 4°C and were rinsed twice in
0.1 M PB for 12 hr. The brains were then incubated in 30% sucrose in 0.1 MPB for approximately 72 hr.
Brains were then blocked into two pieces with a cut in the coronal plane at the caudal border of the
mammillary bodies (approximately –5.30 mm bregma) using a rat brain matrix (RBM‐4000C, ASI
Instruments, Warren, MI, USA). Brains were frozen rapidly in dry‐ice‐chilled liquid isopentane and
stored at −80°C until sectioning. Forebrain sections (25 µm), including the BLA, were cut across the
coronal plane using a cryostat (Leica Biosystems, Buffalo Grove, IL, USA) and stored as six alternate sets
of sections in cryoprotectant (30% ethylene glycol (w/w)/20% glycerol (w/w) in 0.05 MPB, pH 7.4) at
−20°C until immunostaining.

Antibodies

For immunodetection of OCT3, an affinity‐isolated antibody (RRID AB_1622571, rabbit anti‐OCT3, cat #
OCT31A, Alpha Diagnostics International, San Antonio, TX, USA) raised against an 18‐amino acid
sequence in the large intracellular loop of rat OCT3 (amino acids 313–330: HLSSNYSEITVTDEEVSN) was
used. This amino acid sequence is 100% conserved between mouse and rat OCT3 and has no significant
sequence homology with other organic cation/carnitine transporters. The specificity of this antibody
was confirmed previously in immunohistochemical and immunofluorescence applications (Gasser
et al., 2006; Gasser, Orchinik, Raju, & Lowry, 2009; Lips et al., 2005; Yorgason et al., 2016). For
immunodetection of DAT, an affinity‐purified antibody (RRID AB_1586991, rabbit anti‐DAT, cat #
AB2231, MilliporeSigma, Burlington, MA, USA) was used at a dilution of 1:500.

Immunofluorescence

Separate coronal sections (25 µm thick) containing BLA and NAcc were used for detection of OCT3 and
DAT. After rinsing in PBS, sections were incubated overnight with anti‐OCT3 antibody (1:400) or anti‐
DAT antibody (1:500) in phosphate‐buffered saline with 0.1%Tween 20 (PBST). Sections were rinsed
the next day and incubated for 2 hr with fluorophore‐conjugated secondary antibodies (AlexaFluor594‐
conjugated donkey anti‐rabbit; 1:2000; Jackson ImmunoResearch, West Grove, PA, USA). Sections
were then rinsed briefly in PB, mounted onto SuperFrost microscope slides, dried, and coverslipped
with EverBrite antifade mounting medium (Biotium, Fremont, CA, USA).

Imaging

Photomicrographs were acquired using a Nikon 80i microscope fitted with an ORCA‐Flash 4.0LT digital
camera (Hamamatsu, Japan) linked to a computer running NIS Elements‐BR software (Nikon
Instruments, Melville, NY).

Ex vivo fast‐scan cyclic voltammetry

Fast‐scan cyclic voltammetry was used to characterize catecholamine terminal function in the NAcc
and BLA. Brain slices were transferred to testing chambers and incubated in oxygenated ACSF, heated
to 32°C for one hour prior to experiment start. A glass capillary containing a carbon fiber (house‐made;
≈100 µM length, 7 µM radius; Goodfellow Corporation, Berwyn, PA) and a bipolar stimulating

electrode (Plastics One, Roanoke, VA) were placed in close proximity (≈100 µm) on the surface of the
slice. Endogenous catecholamine efflux was induced by a single‐pulse (350 µA, 4 msec, NAcc) or 10‐
pulse stimulation (20Hz, 350 µA, 4 msec/pulse, BLA), applied every five or seven minutes, respectively.
Extracellular catecholamine concentrations were detected by applying a triangular waveform (−0.4 to
+1.2 to −0.4 V vs. silver/silver chloride, 400 V/sec) every 100 milliseconds to the recording electrode
and measuring changes in current at the oxidation potential of dopamine and norepinephrine (~0.6 V).
Pharmacological agents (cocaine and/or CORT; as described in Results) were applied once a stable
baseline was achieved (three consecutive stimulations within 10% of the previous collection).
Electrically evoked catecholamine concentrations were assessed by comparing the current at the peak
oxidation potential for dopamine and norepinephrine to each electrode's calibration to known
concentrations of catecholamine (3.0μM).
Baseline catecholamine release ([CA] per pulse, [CA]/pulse) and the maximal rate of uptake at
catecholamine transporters (𝑉𝑉max ) were analyzed to assess release and uptake (Wightman et al., 1988).
Baseline release and uptake were assessed in every slice that was used for recordings, typically 2–4
slices per animal. Standard Michaelis–Menten modeling procedures were used to assess kinetic
parameters of baseline stimulation before application of cocaine or CORT. [CA]/pulse was calculated as
the amount of catecholamine released per electrical stimulation, and catecholamine uptake was
determined with 𝑉𝑉max and T80, the time it takes for [CA] to decay to 80% of its peak. Km was set to
160 nM for each slice in both regions, based on the known affinity of dopamine for DATs (Vialou,
Amphoux, Zwart, Giros, & Gautron, 2004) while pre‐drug 𝑉𝑉max values were allowed to vary. Because
the affinity of transporters for their endogenous monoamine neurotransmitter (Km) varies across
transporter species, the use of apparent Km (the apparent alteration in affinity of a transporter for its
neurotransmitter based on blockade of that transporter, e.g., inhibition of DAT function with cocaine
application) was not possible in these experiments, given the examination of multiple transporter
species. Therefore, uptake in the NAcc and BLA was assessed using T80, the time it takes for a
catecholamine trace to return to 80% of its peak height, a measure of clearance rate. As dopamine and
norepinephrine are released in the BLA, "catecholamines" (CA) will be used to describe
neurotransmission within this region. All data were collected and analyzed with Demon Voltammetry
and Analysis software (Yorgason, Espana, & Jones, 2011).

Statistics

GraphPad Prism (version 7, La Jolla, CA, USA) was used for all statistical analyses and to prepare all
graphs. Student's t tests were used to determine regional differences in DAT and OCT3 protein levels,
baseline [CA]/pulse and clearance measures, effects of maximal concentrations of cocaine or CORT,
and the relative contribution of the DAT and OCT3 in uptake. A two‐way repeated measures analysis of
variance (ANOVA), with region and drug concentration as factors, was used to determine differences in
cocaine and CORT potency between regions. In the event of significant main effects, Bonferroni post
hoc analysis was used to determine significant group differences. A one‐way ANOVA was used to
calculate the effects of CORT on dopamine release in the NAcc of DAT KO mice. Tukey's post hoc test
was applied when a significant finding was revealed. In voltammetry experiments, 2–4 slices from each
animal were used to determine basal catecholamine kinetics (release and uptake; N = 15–22
slices/group), whereas one slice per animal was used for drug applications (N = 5–10 animals/group).

RESULTS
Carbon fiber microelectrodes have equal sensitivity to dopamine and norepinephrine

Proper identification of electroactive neurotransmitters using voltammetry relies on neurotransmitter
species‐specific cyclic voltammograms, which trace the peak oxidation and reduction potentials of the
neurotransmitter. Notably, the oxidation and reduction potentials of dopamine and norepinephrine
are nearly identical (Heien, Phillips, Stuber, Seipel, & Wightman, 2003), preventing the separation of
these neurotransmitters using voltammetry without the assistance of additional pharmacology.
Electrical stimulation of the NAcc causes dopamine efflux (John & Jones, 2007), while stimulation of
the BLA causes release of both dopamine and norepinephrine (Brinley‐Reed & McDonald, 1999; Zhang,
Muller, & McDonald, 2013). Unfortunately, any pharmacological measures to isolate either dopamine
or norepinephrine in the BLA would further reduce the low catecholamine levels measured in this
region (Jones et al., 1995) and compromise accurate quantification of stimulated neurotransmitter
release. Furthermore, exogenous application of neurotransmitter over the slice does not replicate
electrically stimulated endogenous release with reasonable temporal fidelity, and therefore,
physiological uptake kinetics would be difficult to ascertain utilizing this method. We sought to discern
the sensitivity of our electrodes to each catecholamine to identify any bias to either neurotransmitter
that may influence the interpretation of our experiments. To this end, we flowed a moderately high
concentration (3 μM) of either dopamine or norepinephrine over the carbon fiber microelectrodes. We
chose this concentration in order to more precisely assess sensitivity to the catecholamines through
the production of a somewhat larger signal, while by no means reaching the maximum limit of
detection. Our data show no difference in electrode sensitivity with respect to dopamine versus
norepinephrine (t17 = 0.3516, p = .729; Figure 1a,b), indicating that the carbon fiber microelectrodes
used in the present voltammetry experiments do not favor one catecholamine over the other at the
concentration tested.

1 Electrodes have equal sensitivity to dopamine and norepinephrine. (a) Peak oxidation potentials for dopamine
(DA) and norepinephrine (NE) showed little variation when detected by the same carbon fiber microelectrode.
(b) Within‐electrode analysis revealed no group difference in electrode sensitivity with respect to 3 μM
dopamine and norepinephrine (𝑡𝑡17 = 0.3516, 𝑝𝑝 = . 729). 𝑁𝑁 = 9/group

Catecholamine release is greater and uptake is faster in the NAcc compared to the BLA

To determine regional differences in catecholamine release and uptake kinetics, pre‐drug
catecholamine release and uptake were analyzed. The BLA has reduced catecholamine release
compared to the NAcc (Jones et al., 1995; Yetnikoff, Lavezzi, Reichard, & Zahm, 2014), so stronger
stimulation parameters were used in the BLA (NAcc, single pulse; BLA, 10 pulse/20 hz). For this reason,
release data are analyzed as a measure of catecholamine release per stimulation pulse ([CA]/pulse)

rather than overall catecholamine release (µM). Representative traces of these stimulation parameters
in the NAcc (blue line) and BLA (green line) are depicted in Figure 2a. Two to four slices from each
animal were used to assess release and uptake, prior to subsequent drug application. Student's t test
revealed significantly reduced [CA]/pulse (t19 = 3.558, p < .0001, N = 22 NAcc, N = 17 BLA; Figure 2b) in
the BLA compared to the NAcc. Because lower levels of release, particularly within the BLA, may not be
great enough to ensure clearance at a saturable level consistently (John et al., 2007), we chose to
utilize T80, the amount of time it takes for the voltammetric trace to decay to 80% of its peak height,
rather than 𝑉𝑉max in order to ascertain reuptake rates. The rate of catecholamine uptake was
significantly reduced in the BLA compared to the NAcc as indicated by increased T80 (t34 = 5.828,
p < .0001; N = 22 NAcc, N = 15 BLA Figure 2c). Additionally, we find that 𝑉𝑉max is significantly reduced in
the BLA compared to the NAcc (data not shown) demonstrating that the effect on 𝑉𝑉max is consistent
with T80 data. These data confirm an overall reduction in catecholamine release and uptake dynamics
in the BLA.

2 Catecholamine release is greater and uptake is faster in the NAcc compared to the BLA. (a) Representative
traces of catecholamine (CA) release and uptake from brain slices containing the NAcc and BLA. (b) Evoked CA
release was significantly lower in the BLA compared with to the NAcc (p < .0001). (c) CA uptake, as measured by
T80, of the NAcc is significantly faster than BLA slices (p < .0001). NAcc, nucleus accumbens core; BLA,
basolateral amygdala; CA, catecholamine. N = 15–22 slices/group from 6–8 animals [Colour figure can be viewed
at wileyonlinelibrary.com]

DAT protein levels are higher in the NAcc than in the BLA, but OCT3 protein levels are
similar between regions

Western blot hybridization was used to compare protein levels of DAT and OCT3 in the NAcc and BLA
(N = 8 animals/group). DAT protein content, both 80 kDa (functionally mature; p = .0247) and 60 kDa
(functionally immature; p = .0011) isoforms, was significantly higher in NAcc tissue than in BLA tissue
(Figure 3a,b). OCT3 protein levels were not different between the two regions (p > .05; Figure 3a).
Representative Western blots are shown in Figure 3b.

3 DAT protein levels are higher in the NAcc compared to the BLA, but OCT3 levels are similar between regions.
Western blot hybridization was used to detect and quantitate the observed variations in DAT and OCT3 densities
in the NAcc and BLA. (a) DAT protein levels, normalized to β‐actin, were significantly elevated in the NAcc
compared to the BLA at both 78 kDa (p = .0247) and 56 kDa (p = .0011) molecular weights representing the
mature and immature DAT isoforms, respectively. Conversely, the protein levels of OCT3 were similar in the
NAcc and BLA (p > .05). (b) Representative blot showing NAcc and BLA DAT and OCT3 protein levels quantified in
the graph above. NAcc, nucleus accumbens core; BLA, basolateral amygdala; *p < .05. (N = 8 animals/group)
[Colour figure can be viewed at wileyonlinelibrary.com]

Localization and density of OCT3 and DAT immunoreactivity in the NAcc and BLA

The relative distributions of DAT and OCT3 protein in the NAcc and BLA were examined using
immunofluorescence techniques. DAT‐like immunoreactive fibers were observed in both regions;
however, they occurred at a much higher density in the NAcc than in the BLA (Figure 4). OCT3‐like
immunoreactive perikarya and processes were observed at similar densities in NAcc and BLA (Figure 5).

4 Localization of DAT expression in NAcc and BLA. Fluorescence photomicrographs depicting
immunofluorescence localization of dopamine transporter (DAT) immunoreactivity in the nucleus accumbens (a,
b) and basolateral amygdala (c, d) of the rat. Boxes in (a) and (c) are shown at higher magnification in (b) and (d),
respectively. DAT‐immunoreactive fibers were observed at high density in the nucleus accumbens (b) and dorsal
striatum (c), and at much lower density in the BLA (d). DAT‐immunoreactive fibers were observed at higher
density in the intercalated cell groups (ITC) of the amygdala (c, d) than in the rest of the amygdala. Scale
bar = 200 μm (a, c); 20 μm (b, d). ac, anterior commissure; BLA, basolateral amygdala; ITC, intercalated cell
group; NAcc, nucleus accumbens core; NAcsh, nucleus accumbens shell

5 Localization of OCT3 expression in NAcc and BLA. Fluorescence photomicrographs depicting
immunofluorescence localization of OCT3 immunoreactivity in the nucleus accumbens (a, b) and basolateral
amygdala (c, d) of the rat. Boxes in (a) and (c) are shown at higher magnification in (b) and (d), respectively.
OCT3‐immunoreactive punctae, perikaryae, and processes (arrows in b, d) were observed at similar densities in
both areas. OCT3 perikarya were observed at higher density in the intercalated cell groups (ITC) of the amygdala
(c) than in the rest of the amygdala. Arrows in b, d indicate OCT3‐immunoreactive processes. Scale bar = 200 μm
(a, c); 20 μm (b, d). ac, anterior commissure; BLA, basolateral amygdala; ITC, intercalated cell group

Inhibition of catecholamine uptake by cocaine is greater in the NAcc than the BLA

In order to assess regional differences in the DAT‐mediated catecholamine uptake, we examined the
effects of cocaine, a DAT inhibitor, on catecholamine clearance in the NAcc and BLA (Figure 6, N = 5 per
group). Cocaine inhibits catecholamine uptake through DAT and other monoamine transporters
(Calligaro & Eldefrawi, 1987; Jones et al., 1995; Uhl, Hall, & Sora, 2002; Yorgason et al., 2011), an effect
that is measured as an increase in T80. Figure 6 depicts representative traces collected from NAcc
(Figure 6a) and BLA (Figure 6b) slices before and after stimulation under control conditions and
following incubation with 30 µM cocaine. Two‐way repeated measures ANOVA comparing the effects
of a cumulative cocaine concentration response curve on inhibition of dopamine uptake in the NAcc
and BLA revealed a main effect of region (F1,33 = 18.90, p < .0001; Figure 6c) and drug concentration
(F4,32 = 8.246, p < .0001; Figure 6c) on T80 over the cocaine concentration response curve. Additionally,
an interaction between region and drug dose (F5,35 = 6.835, p < .0008; Figure 6c) was detected.
Bonferroni post hoc analysis demonstrated a significant difference in uptake inhibition between
regions at the 10 µM (p < .05) and 30 µM dose (p < .001). Comparison of T80 at the highest cocaine
concentration as a percentage of pre‐drug T80 in the NAcc and BLA using a Student's t test revealed a
significantly greater potency of cocaine in the NAcc compared to the BLA (t5 = 2.581, p < .0494;
Figure 6d). Of note is a lack of increased release amplitude in the presence of cocaine, which may seem
counterintuitive. However, this is consistent with previous work in our laboratory that demonstrates
biphasic effects of dopamine amplitude with increasing concentrations of cocaine. Augmentation of
signal amplitude with cocaine administration peaks at approximately the 1–3 µM range; however, we
have observed consistently that at greater concentrations, the peak amplitude begins to decline (John
& Jones, 2007; Yorgason et al., 2011). At a concentration of 30 µM, cocaine application no longer

induces an increase in signal amplitude due primarily to activation of presynaptic autoreceptors
(Wieczorek & Kruk, 1994).

6 Inhibition of catecholamine uptake by cocaine is greater in the NAcc compared to the BLA. (a) Representative
traces of evoked catecholamine release and uptake in brain slices containing the nucleus accumbens (NAcc) at
baseline (Pre‐Drug) and 30 µM cocaine (COC), overlaid. (b) Represented traces from basolateral amygdala (BLA)‐
containing brain slices at baseline and 30µM COC overlaid. (c) Cocaine (10 and 30 μM) significantly impaired
catecholamine clearance in the NAcc compared to the BLA, (p < .05, and p < .001, respectively). (d) An increase
in NAcc T80 revealed a significantly greater potency of COC in the NAcc, compared to the BLA (p < .05). NAcc,
nucleus accumbens core; BLA, basolateral amygdala; CA, catecholamine; COC, cocaine; *p < .05; ***p < .001.
N = 5 animals/group [Colour figure can be viewed at wileyonlinelibrary.com]

Inhibition of catecholamine uptake by corticosterone is greater in the BLA than the NAcc

To determine the relative contribution of OCT3 to catecholamine clearance in the NAcc and BLA, we
examined the effects of CORT, which inhibits OCT3‐mediated transport, on catecholamine uptake in
the two regions. Figure 7 depicts representative traces collected from the NAcc (Figure 7a) and BLA
(Figure 7b) before and after stimulation, under control conditions and following treatment with 10 µM
CORT. Two‐way repeated measures ANOVA revealed a dose‐dependent increase in catecholamine
clearance time, T80, in the BLA across the concentration response curve (F4,42 = 3.929, p < .0085;
Figure 7c). Bonferroni post hoc analysis revealed a significant difference in T80 between regions at the
3.0 µM (p < .01) and 10 µM (p < .01) concentrations. Student's t test of group data at the highest CORT
concentration tested (10 µM) further underscores the potency CORT to inhibit uptake in the BLA
(t8 = 2.368, p < .0454; Figure 7d).

7 Corticosterone inhibits uptake more in the BLA than the NAcc. (a) Representative traces from the nucleus
accumbens (NAcc) at baseline and 10 µM corticosterone (CORT) overlaid. (b) Representative basolateral
amygdala (BLA) traces at baseline and 10 µM CORT overlaid. (c) CORT (3 and 10 μM) significantly inhibited

catecholamine uptake in the BLA compared to the NAcc, (p < .01 and p < .001, respectively). (d) CORT (10 μM)
significantly increased T80 in the BLA compared to the NAcc (p < .05). NAcc, nucleus accumbens core; BLA,
basolateral amygdala; CA, catecholamine; CORT, corticosterone; *p < .05; **p < .01. N = 5–8 animals/group
[Colour figure can be viewed at wileyonlinelibrary.com]

Corticosterone increases dopamine clearance time in the NAcc of DAT KO mice

CORT treatment had a much smaller effect on inhibiting catecholamine uptake in the NAcc than in the
BLA. We believed this was likely because the high levels of DAT expression in the NAcc mask the effects
of CORT‐induced inhibition of OCT3. To examine the contribution of OCT3 function in the NAcc in the
absence of DAT, we examined the effects of CORT on catecholamine clearance in NAcc slices obtained
from DAT KO mice. A one‐way ANOVA revealed that CORT treatment increased catecholamine
clearance time over the concentration response curve (F4,23 = 3.676; Figure 8). Tukey's post hoc
analysis revealed a significant increase in T80 at the 10 µM concentration versus baseline (p < .05).

8 Corticosterone increases dopamine clearance time in the NAcc of DAT KO mice. Corticosterone (CORT) dose
dependently decreased catecholamine clearance in DAT KO mice, indicated by an increase in T80 time (p < .05).
DAT KO, dopamine transporter knockout mice; *p < .05. N = 6 animals [Colour figure can be viewed at
wileyonlinelibrary.com]

Catecholamine clearance in the NAcc is governed by DATs while clearance in the BLA
involves OCT3 activity

To better compare the relative contribution of DAT and OCT3 to catecholamine uptake in the NAcc and
BLA, catecholamine uptake was measured twice in NAcc and BLA slices: first after incubation with the
maximum concentration of cocaine studied here (30 µM), and second after the addition of the
maximum concentration of CORT tested here (10 µM), in the presence of cocaine. Representative NAcc
and BLA traces can be seen at baseline, following incubation with 30 µM cocaine, and after incubation
with cocaine +10 µM CORT (Figure 9a–d). The effect of CORT on clearance was expressed as the CORT‐
induced increase in T80 as a percentage of the cocaine‐induced T80. Student's t test revealed that
magnitude of the CORT‐induced increase in T80 as a percent of cocaine‐induced changes in T80 was
greater in the BLA than in the NAcc (t15 = 2.268, p < .0386; Figure 9e). Of note, it can be seen that
release amplitude is reduced in the NAcc with the combination of cocaine and CORT, but this effect is
not present in the BLA.

9 Catecholamine clearance in the NAcc is governed by DAT function while catecholamine clearance in the BLA
favors OCT3 activity. (a) Representative traces of the nucleus accumbens (NAcc) at baseline, (b) after incubation
with 30 µM cocaine (COC; solid line) and after the addition of 10 µM corticosterone (CORT; dashed line). (c)
Traces from BLA slices at baseline, (d) after incubation with 30 µM COC (solid line), and after the addition of
10µM CORT (dashed line). (e) Increases in T80 due to CORT application as a percent of post‐COC clearance time
revealed a greater effect of CORT on uptake inhibition in the BLA compared to the NAcc. NAcc, nucleus
accumbens; BLA, basolateral amygdala; COC, cocaine (COC); CORT, corticosterone CORT; *p < .05. N = 7–10
animals/group [Colour figure can be viewed at wileyonlinelibrary.com]

DISCUSSION

Dopaminergic signaling in the NAcc and BLA contributes to the regulation of affect (Chartoff &
Carlezon, 2014; Diaz et al., 2011; Ferry et al., 2015) and motivated behaviors (Fish et al., 2014;
Nakamura et al., 2014; Shiflett & Balleine, 2010; Simmons & Neill, 2009). The magnitude of
catecholamine effects in a given region can be regulated by alterations in release magnitude and
uptake kinetics. Previous work (Jones et al., 1995) and the present study describe reduced
catecholamine release and slower uptake in the BLA compared to the NAcc. The present work aimed to
expand our understanding of uptake mechanisms in these regions by examining the expression and
activity of two catecholamine transporters that mediate clearance of extracellular catecholamines in
the NAcc and BLA. The present studies demonstrated that the expression of DAT protein is greater in
the NAcc than in the BLA and that OCT3 protein expression is similar between regions. Consistent with
the transporter expression data, ex vivo voltammetry data demonstrated that the DAT inhibitor
cocaine inhibits catecholamine uptake to a greater extent in the NAcc than in the BLA, while the OCT
inhibitor CORT exerted a greater inhibitory effect in the BLA than in the NAcc. We suspect that
differences in uptake rates are due to regional differences in the density of transporter expression. The
distinct uptake mechanisms in the NAcc and BLA may contribute to differential regulation of
catecholamine neurotransmission within these regions.

The magnitude of catecholamine release is significantly lower in the BLA than in the
NAcc

While the present work mainly focused on differences in catecholamine uptake in the NAcc and the
BLA, presynaptic mechanisms influencing catecholamine release also play a major role in shaping
catecholamine signaling. The present findings using fast‐scan cyclic voltammetry corroborate previous
work demonstrating that stimulated catecholamine release is significantly greater in the NAcc than in
the BLA (Jones et al., 1995). While we did not further explore release mechanisms here, we and others
have previously examined many potential modulators of catecholamine release that may differ
between the NAcc and the BLA. Previous studies have shown that dopamine D2 and D3 autoreceptors
(Maina & Mathews, 2010) and ⍺2‐adrenergic autoreceptors reduce catecholamine release (Garcia
et al., 2004) in subnuclei of the NAcc (Ihalainen & Tanila, 2004; Maina & Mathews, 2010) and BLA
(Ferry et al., 2015; Gurevich & Joyce, 1999; Perez de la Mora et al., 2012; Stevenson & Gratton, 2004).
It is possible that differences in dopaminergic and noradrenergic autoreceptor expression between the
NAcc and BLA may contribute to differential dopamine release in these two regions. Additionally, we
have shown that kappa opioid receptor‐mediated inhibition of dopamine release in the NAcc is
associated with negative affect‐like behaviors in rodents (Karkhanis, Rose, Weiner, & Jones, 2016; Rose
et al., 2016). Kappa opioid receptors are densely expressed in both the NAcc and the BLA, where their
activation leads to reductions in presynaptic release of neurotransmitters, including dopamine, and
differential receptor function or expression could also influence release kinetics from these regions
(Svingos, Chavkin, Colago, & Pickel, 2001; Thompson et al., 2000; Werling, Frattali, Portoghese,
Takemori, & Cox, 1988). Future work aimed at differentiating release mechanisms between these
regions will further aid in refining therapeutic treatment strategies for disorders of negative affect and
substance use disorders.

Cocaine and corticosterone were more potent at inhibiting uptake rates in the NAcc and
BLA, respectively

Catecholamine clearance is a complex, regionally variable process. Our Western blot and
immunofluorescence findings reveal that while OCT3 is expressed at similar levels in NAcc and BLA,
DAT expression is significantly greater in the NAcc than in the BLA. These data are consistent with
previous studies demonstrating abundant DAT protein in the NAcc (Gurevich & Joyce, 1999; Perez de la
Mora et al., 2012), and OCT3 more uniformly distributed throughout the brain (Gasser et al., 2009).
Transporter protein density is not the sole determinant of overall transporter function. Although
Western blot data here show higher levels of DAT in the NAcc compared to the BLA, differences in
membrane localization and transport modulators, among other factors, can contribute to differences
in transporter function between regions (Kivell et al., 2014; Rao, Sorkin, & Zahniser, 2013). Studies
examining the relative subcellular localizations of DAT and OCT3 and their proximity to dopamine
receptors would be particularly informative. While colocalization of these transporters has not been
examined (Gasser, 2018), ultrastructural studies have demonstrated that OCT3 is localized to dendritic
spines and presynaptic terminals in the BLA (Gasser et al., 2017), suggesting important roles for the
transporter in regulating perisynaptic monoamine concentrations. OCT3 expression has also been
observed on DAT+ neurons (Mayer et al., 2018), suggesting possible co‐expression at dopamine
terminals. Interestingly, OCT3 also appears to be present on striatal cholinergic neurons (Vialou,

Balasse, Dumas, Giros, & Gautron, 2007), which strongly regulate terminal dynamics in the nucleus
accumbens (Melchior, Ferris, Stuber, Riddle, & Jones, 2015; Siciliano, McIntosh, Jones, & Ferris, 2017;
Yorgason, Rose, McIntosh, Ferris, & Jones, 2015). Therefore, it is possible that there may be additional
effects of OCT3 activity on cholinergic neurons, which may alter catecholamine clearance kinetics.
While localization studies will certainly be necessary for future delineation of the mechanisms of OCT3
function, we chose to focus on catecholamine clearance as a functional output of DAT and OCT3
activity.
With these studies in mind, we evaluated the functional importance of the DAT and OCT3 in the NAcc
and BLA with slice voltammetry using cocaine and CORT to inhibit DAT and OCT3 function, respectively.
The concentrations of both cocaine and corticosterone utilized in this study are admittedly somewhat
high compared to physiological levels in the presence of systemic cocaine or stress exposure, although
they are difficult to directly compare. For instance, repeated administration of 1 mg/kg cocaine over 10
injections in anesthetized rats does begin to show the characteristic decline in maximal dopamine
amplitude that we observe (and have commented on here) with higher concentrations of cocaine on
slice (Brodnik, Ferris, Jones, & Espana, 2017); however, this effect is not accompanied by uptake
inhibition that is as dramatic as is observed with higher concentrations of cocaine on slice. Similarly,
corticosterone concentrations used here are around 1–2 orders of magnitude higher than brain levels
of corticosterone following administration of stressors in vivo (Makino, Gold, & Schulkin, 1994; Pitman,
Ottenweller, & Natelson, 1988; Sullivan & Gratton, 1998), though the concentration response curve for
corticosterone in Figure 8 does more closely approximate this range. Here, we have chosen somewhat
higher concentrations that we and others have published previously in ex vivo studies in order to more
clearly observe effects on reuptake (Caliskan et al., 2015; Yorgason et al., 2011).
Cocaine inhibited uptake more in the NAcc, which expresses higher levels of DAT protein, than in the
BLA. The fact that CORT was more effective at reducing catecholamine uptake in the BLA than NAcc,
despite our evidence that OCT3 protein levels were similar in the two regions, is likely due to the
abundant expression of DAT in the NAcc. Thus, the effects of OCT3 inhibition are likely obscured by
continued abundant DAT activity in the presence of CORT.
This interpretation was supported by our data examining CORT effects on catecholamine clearance in
DAT KO mice, in which CORT is better able to inhibit catecholamine clearance. It is likely that CORT
inhibits catecholamine uptake in the NAcc of wild‐type animals, but that the effect is not detectable
due to the high levels of DAT activity. It is important to note that, as with any constitutive knockout
approach, some of the effects observed in the DAT KO mouse line may be mitigated at least in part by
compensatory mechanisms that could be driving altered OCT3 function in these animals. However,
consistent with our findings, a recent study reported that CORT treatment decreased the clearance of
naturally occurring dopamine transients in the NAcc even in the absence of DAT blockade (Wheeler
et al., 2017). These studies also demonstrated that CORT pre‐treatment potentiates the effect of a
previously sub‐threshold dose of cocaine on NAcc dopamine clearance.
Though the findings outlined here appear at the surface to report relatively straightforward
phenomena, it should be noted that there are many factors modulating uptake kinetics and should not
be viewed as overly simplistic. As noted above, the cyclic voltammograms for dopamine and
norepinephrine are virtually identical, making it difficult to identify which neurotransmitter kinetics are

being affected by a given treatment through voltammetry assessment alone. This is particularly
problematic in the BLA, where dopamine and norepinephrine are estimated to be released at similar
concentrations. Blockade of either CA either pharmacologically or using optogenetic stimulation
approaches is particularly troublesome in the BLA, a region with limited stimulated catecholamine
release. Though one possible solution could involve application of exogenous neurotransmitter, this
approach is troublesome in that temporal kinetics observed with electrical stimulation are difficult to
faithfully replicate in a slice preparation.
Other monoamine transporters in addition to DAT and OCT3 are also likely to contribute to CA
clearance, especially in the BLA. The norepinephrine transporter is capable of clearing catecholamines
at equal or greater efficacy than the DAT and is expressed at similar levels between the accumbens and
BLA in humans (Smith, Beveridge, & Porrino, 2006). In rodents, NET plays a far larger role in
catecholamine reuptake in the nucleus accumbens shell, where greater norepinephrine innervation is
observed, than in the NAc core, which is primarily dopaminergic (Carboni, Silvagni, Vacca, & Di
Chiara, 2006). However, in regions with high norepinephrine innervation, such as the BLA, NET
consistently plays a critical role in clearance of both norepinephrine and dopamine (Carboni
et al., 2006). Though beyond the scope of this study, it would be interesting to ascertain the role of
NET in concert with DAT and OCT3 in differential uptake kinetics, particularly within the BLA.
Additionally, other low‐affinity, high‐capacity transporters with Uptake2‐like function—OCT1, OCT2,
and PMAT—may contribute to CA clearance. These transporters also function to clear monoamines
from the extracellular fluid and are inhibited to CORT. Among the Uptake2 transporters, OCT3 has the
highest sensitivity to CORT (Gasser, 2018) and is expressed at greater density in the NAcc and BLA than
other OCT isoforms (Amphoux et al., 2006). PMAT is expressed in relatively similar levels between the
NAcc and BLA (Dahlin, Xia, Kong, Hevner, & Wang, 2007) and has greater affinity for dopamine than
norepinephrine (Duan & Wang, 2010). Future studies examining the role of this transporter in
differential uptake kinetics between the NAcc and BLA will shed further light on Uptake2 transporters
in monoamine signaling, particularly with regard to dopaminergic signaling. Interestingly, it has been
recently demonstrated that CORT, via inhibition of OCT3, potentiates the effect of a low systemic dose
of cocaine on dopamine clearance in the NAc (Wheeler et al., 2017). This work both differs from and
compliments our own in some regards: While this study was performed in awake and behaving animals
with a low dose of cocaine, we also observed further inhibition of uptake with a high concentration of
cocaine over a deafferented slice when CORT was applied in the bath. It is important to note that OCT3
is canonically cocaine‐insensitive at concentrations consistent with our data (Gasser and Lowry, 2018).
The ability of CORT to augment cocaine's effects of uptake inhibition resonates in behavioral studies
outlined below.
Of note, we do find that CORT applied following cocaine decreases release amplitude in the NAcc, but
not the BLA. While the reason for this difference is not completely clear, it is known that this
combination of drugs enhances spontaneous dopamine release transients as well as reducing uptake
(Graf et al., 2013; Wheeler et al., 2017), we hypothesize that elevated extracellular levels of dopamine
in the slice tonically activate presynaptic D2‐type autoreceptors, which then inhibit electrically evoked
release in the NAcc (Wieczorek & Kruk, 1994). The BLA may not exhibit this effect because dopamine
terminals in the BLA have fewer presynaptic autoreceptors and are much less sensitive to

autoreceptor‐mediated inhibition of release than in the NAcc (Garris & Wightman, 1995). These
aspects of NE regulation in the BLA are unknown and require further exploration.

The behavioral implications of elevated corticosterone in the NAcc and BLA

OCT3 is directly and specifically inhibited by CORT, a hormone released in rodents during times of
stress (Baganz et al., 2010; Wieland et al., 2000). Indeed, augmented levels of CORT have been
measured in the NAcc (Yu et al., 2013) and BLA (Bouchez et al., 2012), following exposure to a stressor.
Our findings support previous work that demonstrated CORT‐induced inhibition of dopamine clearance
in the NAcc in the presence of the DAT inhibitor GBR12909 (Graf et al., 2013). These data specifically
implicate OCT3 in increased extracellular catecholamine levels during times of stress. Further, through
OCT3, CORT is able to augment the ability of a low dosage of systemic cocaine to inhibit uptake of
dopamine in the NAcc of an awake and behaving rat (Wheeler et al., 2017). A growing body of
literature suggests that augmented CORT, via inhibition of OCT3‐mediated dopamine clearance,
potentiates cocaine‐induced reinstatement of drug‐seeking behavior (Graf et al., 2013; McReynolds
et al., 2017). It is possible that increased CORT, and subsequent reduction in catecholamine uptake in
the NAcc and BLA, drive complementary aspects of drug abuse‐related behaviors.
We hypothesize that in individuals with a substance use disorder, stress‐induced increases in
glucocorticoids potentiate the effects of sub‐threshold stimuli on catecholamine concentrations in the
NAcc and BLA, thus "priming" the subject to seek substances of abuse. For example, previous work has
shown that increased catecholamine signaling in the BLA is anxiogenic (Bananej et al., 2012; Diaz
et al., 2011), and CORT‐mediated increases in dopamine transmission may underlie stress‐induced
increases in the motivation for drug self‐administration, as discussed above (Graf et al., 2013). In fact,
humans (Lopez‐Castro, Hu, Papini, Ruglass, & Hien, 2015; Min, Farkas, Minnes, & Singer, 2007; Sullivan
et al., 2015) and rodents (Briand & Blendy, 2013; Funk, Li, & Le, 2006) exposed to stressors have
augmented drug‐seeking behaviors. Moreover, during long periods of abstinence characterized by
augmented CORT levels, rats with a history of cocaine self‐administration exhibited increased drug
seeking (Lack et al., 2008). Despite strong evidence supporting our hypothesis, additional in vivo work
examining the specific contribution of NAcc and BLA OCT3 blockade to stress‐induced drug seeking is
necessary.

CONCLUSIONS

We explored the expression of DAT and OCT3, and their contribution to catecholamine clearance, in
the NAcc and BLA. Our findings demonstrate the existence of distinct mechanisms of catecholamine
release and clearance in the NAcc and BLA. Specifically, we report that OCT3 blockade significantly
reduces catecholamine uptake in the BLA compared to the NAcc, while cocaine is more effective at
reducing uptake in the NAcc. We suspect that OCT3 removes excess synaptic catecholamines in the
NAcc when transporters are saturated due to high release volumes, or when transporters are
pharmacologically inhibited, for example by psychostimulant drugs of abuse. This putative DAT‐OCT3‐
mediated process allows for the relative maintenance of homeostasis within the synapse under normal
conditions. However, in times of stress, blockade of OCT3 is hypothesized to augment catecholamine
concentrations in the BLA and NAcc and prime the subject for drug‐seeking behavior (Graf et al., 2013;
McReynolds et al., 2017).
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